Development and Validation of a Tuberculosis Medication Adherence Scale

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Yin, Xiaoxv ^a   Tu, Xiaochen ^a   Tong, Yeqing ^b   Yang, Rui ^a   Wang, Yunxia ^a   Cao, Shiyi ^a   Fan, Hong ^c   Wang, Feng ^d   Gong, Yanhong ^a   Yin, Ping ^a   Lu, Zuxun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hubei Center for Disease Control and Prevention   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; COMMUNITY CARE; CONSTRUCT VALIDITY; CONTENT VALIDITY; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTIVE VALUE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SCORING SYSTEM; SEMI STRUCTURED INTERVIEW; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY; TUBERCULOSIS; TUBERCULOSIS MEDICATION ADHERENCE SCALE;

ADULT; AGED; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84871195240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050328     Document Type: Review

References (26)

1. WHO (2007) Global Tuberculosis Control: surveillance,planning, financing. Geneva: World Health Organization.
2. Obermeyer Z, Abbott-Klafter J, Murray CJ, (2008) Has the DOTS strategy improved case finding or treatment success? An empirical assessment. PLoS One 3: e1721.
3. Khan MA, Walley JD, Witter SN, Shah SK, Javeed S, (2005) Tuberculosis patient adherence to direct observation: results of a social study in Pakistan. Health Policy Plan 20: 354-365.
4. Walley JD, Khan MA, Newell JN, Khan MH, (2001) Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 357: 664-669.
5. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M, (1998) Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 352: 1340-1343.
6. Jianming W, Hongbinh S, (2009) Direct observation and completion of treatment of tuberculosis in rural areas of China. Scand J Public Health 37: 304-309.
7. Sun Q, Meng Q, Yip W, Yin X, Li H, (2008) DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis 12: 625-630.
8. Volmink J, Garner P, (2000) Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 10.1002/14651858.cd000010: CD000010.
9. Volmink J, Matchaba P, Garner P, (2000) Directly observed therapy and treatment adherence. Lancet 355: 1345-1350.
10. WHO (2002) An expanded DOTS framework for effective TB control.Geneva: World Health Organization.
11. WHO (2003) Treatment of tuberculosis: guidelines for national programmes (3rd edition). Geneva: World Health Organization.
12. Hahn SR, Park J, Skinner EP, Yu-Isenberg KS, Weaver MB, et al. (2008) Development of the ASK-20 adherence barrier survey. Curr Med Res Opin 24: 2127-2138.
13. Morisky DE, Green LW, Levine DM, (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67-74.
14. Svarstad BL, Chewning BA, Sleath BL, Claesson C, (1999) The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 37: 113-124.
15. Thompson K, Kulkarni J, Sergejew AA, (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 42: 241-247.
16. Garfield S, Clifford S, Eliasson L, Barber N, Willson A, (2011) Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review. BMC Medical Research Methodology 11: 149.
17. Coly A, Morisky D, (2004) Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles. Int J Tuberc Lung Dis 8: 703-710.
18. Morisky DE, Malotte CK, Choi P, Davidson P, Rigler S, et al. (1990) A Patient Education Program to Improve Adherence Rates with Antituberculosis Drug Regimens. Health Education & Behavior 17: 253-266.
19. Steiner JF, Prochazka AV, (1997) The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50: 105-116.
20. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, et al. (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15: 59-66.
21. WHO (2011) The World Medicines Situation 2011. Available: http://apps.who.int/medicinedocs/documents/s18064en/s18064en.pdf [accessed April 23, 2012].
22. Zhao l, Xie X, Shen Y, (2005) Research Analysis on Medication Adherences of Tuberculosis Patients. China Pharmacy 16: 1311 [in Chinese].
23. Wang L, Liu J, Chin DP, (2007) Progress in tuberculosis control and the evolving public-health system in China. Lancet 369: 691-696.
24. Hu D, Liu X, Chen J, Wang Y, Wang T, et al. (2008) Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan 23: 43-55.
25. Xu W, Lu W, Zhou Y, Zhu L, Shen H, et al. (2009) Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res 9: 169.
26. Cao S, Zhao L, Lu Z, (2011) The Effect Assessment of the Cooperation Model of Tuberculosis Special Hospitals and Tuberculosis Dispensaries. Chinese J Socail Med 28: 125-127 [in Chinese].